IL84849A - Skin care aftershave containing antiseptic or antibacterial components - Google Patents

Skin care aftershave containing antiseptic or antibacterial components

Info

Publication number
IL84849A
IL84849A IL8484987A IL8484987A IL84849A IL 84849 A IL84849 A IL 84849A IL 8484987 A IL8484987 A IL 8484987A IL 8484987 A IL8484987 A IL 8484987A IL 84849 A IL84849 A IL 84849A
Authority
IL
Israel
Prior art keywords
formulation
aftershave
glycol
agent
derivatives
Prior art date
Application number
IL8484987A
Other versions
IL84849A0 (en
Inventor
Sarah Weinraub
Original Assignee
Ramot University Authority Fro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot University Authority Fro filed Critical Ramot University Authority Fro
Priority to IL8484987A priority Critical patent/IL84849A/en
Publication of IL84849A0 publication Critical patent/IL84849A0/en
Publication of IL84849A publication Critical patent/IL84849A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

iivfl ηΐ3>\? nib** >» SKIN CARE AFTERSHAVE Containing antiseptic or antibacterial components SKIN CARE AFTERSHAVE 84849/4 This invention relates to aftershave preparations specifically those containing antibacterial antibiotic antiseptic or retinoic acid components.
The need for aftershave preparations containing antibiotic or retinoic acid components rises in particular for treatment of acne (a chronic inflammatory disorder of the pilosebaceous follicles) most commonly occuring to children in the age of 14-19, especially to boys during their first shaving years.
Children (boys in particular) in the age group of 14-19 have shown to resent using the standard treatment given for acne in form of a face lotion containing antibiotics, or such face cream, or such masks.
It is the purpose of this invention to combine the use of an aftershave lotion, cream or emulsion having the standard formulation of an aftershave (alcohol, cooling agent etc), and including in said formulation a required amount of an antibiotic agent which known to have sufficient antibacterial activity, or retinoic acid, which will provide the user (daily) with the needed medication to combat Acne.
Simmilar preparations could also be used for . body or legs lotions or creams to be used after shaving or . depillating of legs or underarm hair by women having any inflammatory wounds, or infiammed skin in the area shaved or depillated. The contents of the aftershave formula will have to be adjusted to this use, by reducing the alcohol contents, but the presence of the antibiotic ingredient or the retinoic acid should be in the same proportions to provide treatment. s Acne is predominantly caused by genetic factors, and is confined to areas where the sebaceous glands are developed. 84849/4 Hormone production (androgen) serves an important role of acne occurence, and androgen induces acne apperance in susceptible regions. Where acne appears one usually finds bacterial infection (corynebacteriam and staphylococcus epidermitis).
Treatment of acne beyond diet instructions and ellimination of contact of the skin with known acneigenic agents such as cheap brilliantine etc. is either by Endocrine preparations containing progesterone or estrogens, which have little scientific logic and little proof of effectiveness; or the more common and recomended treatment using a wide range of antibiotics with broad-spectrum.
The antibiotics known to have good control of the inflammatory changes of acne are: systemically; tetracyclines - (effective in 7-10 days with dossages of 250-1000mg daily), or topically; 1% Erythromycin, or 1% clindamycin (known commercially as DalacineR), 1% of Neomycin (A,B,C), or 1% chloramphenicol (known commercially as synthomycetine). These are usually applied by different topical treatment in form of creams, lotions, masks. They must be applied for weeks or months to be effective and hence cause resistance and resentment by the young patient.
Other non antibiotic bacteriostatic agents - have been known to be used they include such active ingredients as: Sulphonamides (having a risk of side effects,) retinoic acid.
All these are also formulated in creams, lotions or the like and have the same drawback that young patients do not wish to apply them for long periods, either because of lack of time; or unpleasant feeling caused to 1 boys when they need to treat themselves with creams or masks; or odour or other unpleasant side-effects caused by the cream or lotion. 84849/4 The invention herein provides for an after-shave formulation containing of the knwon antibiotic agents or retinoic acid.
The preferred aftershave formulation will contain: a cooling agent such as menthol 0.01-0.3% a glycol or paraffin such as propylene glycol 15-30% a perfume 0-3% an antibiotic agent or retinoic acid 0.01-2% ethanol to make up to 100%.
The antibiotic agent could be one or a mixture of the following: Tetracycline, Erythromycin, Clindamycin, Neomycin, Chloramphenicol (known commercialy as Syntomycetine), certimonium bromide.
The preparation will either be in form of a clear aftershave lotion, or an aftershave cream or an emulsion.
In another prefered embodiment the said glycol could be either glycerine or hexylene glycol or the like.
In a further embodiment the preparation can be made for use by women to treat their legs or underarms after shaving or depillating hair. The preparation would in such a case contain a higer content of the paraffin or glycol (or glycerine) to the extent of 30-50% and the enthanol content will be reduced or replaced partially by purified water.
The invention can be best demonstrated by way of the attached examples: 84849/4 Examples 1 An aftershave preparation was prepared by mixing the following materials: lay. weight Clindamycin 1 % Menthol 0.1% Propyleneglycol 24% Perfume 1% Ethanol 73.9% This aftershave was tested by a panel of 20 boys in the age range of 15-19, all in their first years of shaving, all having some extent facial acne occurance. By daily use of the lotion after shaving great improvement of acne wounds was observed after six weeks.
Example 2 An aftershave lotion preparation was prepared by mixing the following materials: by weight Erythromycin 1 % Menthol 0.1% Propylene glycol 24% Ethanol 73.9% The after shave lotion was tested on a panel of 20 boys in the age range of 15-19, all in their first shaving years, all having to some extent facial acne occurance. After six weeks of daily use of the lotion, it was ab served that most acne wounds dissapeared.

Claims (18)

84849/4 What is claimed
1. An aftershave formulation in form of lotion cream or emulsion having the standard formulation of an aftershave (alcohol, cooling agent etc.,) which includes 0.01-2% amount of an antibiotic agent or retinoic acid, which known to have sufficient antibactrial activity .
2. A formulation as in claim 1 of the general formula: an antibiotic agent 0.01-2% a cooling agent 0.01-0.3% a perfume 0-3% a glycol (or paraffin) 15-30% Ethanol, or a mixture of ethanol and purified water to make up 100%.
3. A formulation as in claim 1 or 2 wherein the antibiotic agent is tetracyline Hcl or its derivative.
4. A formulation as in claim 1 or 2 wherein the antibiotic agent is: Erythromycin, or its derivatives.
5. A formulation as in claim 1 or 2 wherein the antibiotic agent is: clindamycin or its derivatives.
6. A formulation as in claim 1 or 2 wherein the antibiotic agent is: Neomycin or its derivatives.
7. A formulation as in claim 1 or 2 wherein the antibiotic agent is: chloramphenicol or its derivatives.
8. A formulation as in claim 2 wherein the active agent instead of the antibiotic is: retinoic acid or its derivatives.
9. A formulation as in claims 2-8 wherein the glycol is propylene glycol.
10. A formulation as in claims 2-8 wherein the glycol is glycerine.
11. A formulation as in claims 2-8 wherein the glycol is hexylene glycol.
12. A formulation as in claims 2-8 wherein liquid paraffin is used instead of glycol.
13. A formulation as in claims 2-12 wherein the cooling agent is menthol 0.1 % by weight.
14. A formulation as in claims 1-12 in form of a clear aftershave lotion.
15. A formulation as in claims 1-12 in form of an emulsion, used as an aftershave, or treatment after depillating hair. s 84849/4
16. A formulation as in claims 1-12 in form of a cream used as an aftershave, or treatment after depillating hair.
17. A formulation as in claims 1-12 used as a treatment against acne.
18. A formulation as in claims 1-17 used as a treatment of inflammatory wounds caused by a bacterial infection after shaving or depillating hair. 19 A formulation as essentially claimed in claims 1-18 described in the attached examples. 3-TJ-O
IL8484987A 1987-12-16 1987-12-16 Skin care aftershave containing antiseptic or antibacterial components IL84849A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL8484987A IL84849A (en) 1987-12-16 1987-12-16 Skin care aftershave containing antiseptic or antibacterial components

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL8484987A IL84849A (en) 1987-12-16 1987-12-16 Skin care aftershave containing antiseptic or antibacterial components

Publications (2)

Publication Number Publication Date
IL84849A0 IL84849A0 (en) 1988-06-30
IL84849A true IL84849A (en) 1994-07-31

Family

ID=11058400

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8484987A IL84849A (en) 1987-12-16 1987-12-16 Skin care aftershave containing antiseptic or antibacterial components

Country Status (1)

Country Link
IL (1) IL84849A (en)

Also Published As

Publication number Publication date
IL84849A0 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
US4607101A (en) Method of treating acne vulgaris with a composition containing carbamide peroxide
US5425954A (en) Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use
US5466446A (en) Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
US5990100A (en) Composition and method for treatment of psoriasis
AU706143B2 (en) Antiodor, antimicrobial and preservative compositions and methods of using same
EP1420645B1 (en) Multivesicular emulsion topical delivery systems
US5762945A (en) Composition and method for treating diaper rash
US4301145A (en) Antiseptic skin cream
KR880000091A (en) Topical Pharmaceutical Compositions Method of Preparation and Use thereof
CA2256960A1 (en) High glycerin containing anti-microbial cleansers
EP0215108B1 (en) Compositions for treating acne vulgaris and methods of making same
EP0150914A2 (en) Skin treatment composition
Guaguere Topical treatment of canine and feline pyoderma
JP2005524651A (en) Topical dapsone for the treatment of acne
US4034114A (en) Treatment of skin keratoses with retinal
Tosti et al. Allergic contact dermatitis due to povidone-iodine.
US3663716A (en) Method of treating acne with benzyl alcohol
US5435997A (en) Topical agent and method for the treatment of pseudofolliculitis barbae
US4055662A (en) Antimicrobial composition containing 10-undecensic acid isopropylic ester
US5886038A (en) Composition and method for treatment of psoriasis
US4250164A (en) Method of treating psoriasis of the nails and composition
US4035510A (en) Treatment of acne utilizing N-methyldiethanolamine
JPH0259507A (en) Hair care composition
IL84849A (en) Skin care aftershave containing antiseptic or antibacterial components
EP0086228B1 (en) Use of carbamide peroxide for the manufacture of a medicament for treatment of acne vulgaris

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees